-
Gilead Sciences Inc. (GILD $114.51)
-
AbbVie Inc. (ABBV $197.19)
-
Johnson & Johnson (JNJ $171.04)
-
Medtronic plc. (MDT $89.64)
-
Pfizer Inc. (PFE $23.53)
Q: Recently, 5i has supported members' suggestions to switch out of JNJ into something else given the legal difficulties that JNJ faces. I generally like to hold indefinitely; given this anticipated time frame, and my preference for safety and a good/growing dividend, do you think I should switch as well? Do you view the alternatives I've listed as less or more risky than JNJ overall? Are there non-pharmaceutical alternatives in the US healthcare space that would provide an equally secure and growing dividend that you would recommend? Thank you.